The Federal Circuit affirmed-in-part and vacated-in-part a jury verdict of non-infringement and invalidity for certain asserted claims of CellTrust Corporation's U.S. Patent Nos. 9,775,012 and 10,778,837, which cover systems and methods for tracking electronic communications. CellTrust appealed the district court's denial of JMOL on infringement and validity, as well as denial of its motion for new trial, primarily challenging a post-trial claim construction that allegedly imported a "directly" limitation into the claims' "sending" requirements and the district court's refusal to give a corroboration jury instruction regarding defendants' expert testimony on obviousness.
The court held that CellTrust forfeited its claim construction argument by failing to request construction of "sending" before trial or object to the jury instructions before the jury retired, following Ecolab and LifeNet Health. Substantial evidence supported the jury's non-infringement verdict under the instructions given, particularly where CellTrust's expert admitted he did not examine source code, could not read code, and did not know how communications were sent after leaving the accused server. On validity, the court found any error in omitting a corroboration instruction was harmless under Eighth Circuit standards because defendants' expert testimony was sufficiently corroborated through circumstantial evidence, other witness testimony, and trial exhibits—including CellTrust's own expert's concessions and documentary evidence regarding the Google prior art at issue. The court vacated only the overbroad judgment language that addressed all claims of the patents rather than just the asserted claims, remanding for correction of this clerical error under Rule 60(a).